|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 |
| (11) | Number of the document | 2217213 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08844404.7 |
| Date of filing the European patent application | 2008-10-29 | |
| (97) | Date of publication of the European application | 2010-08-18 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/081496 |
| Date | 2008-10-29 |
| (87) | Number | WO 2009/058798 |
| Date | 2009-05-07 |
| (30) | Number | Date | Country code |
| 983973 P | 2007-10-31 | US |
| (72) |
BUNICK, Frank, US
LUBER, Joseph, US
|
| (73) |
Johnson & Johnson Consumer Inc.,
199 Grandview Road, Skillman, NJ 08558,
US
|
| (54) | ORALLY DISINTEGRATIVE DOSAGE FORM |
| ORALLY DISINTEGRATIVE DOSAGE FORM |